|Last Price||Today's Change||52-Week Range||Trading Volume|
|32.30||-0.02 (-0.06%)||30.05 - 55.99||719.7 thousand (Below Avg)|
Market data as of 4:00PM 01/23/15. Quotes are delayed by at least 15 min.
Seattle Genetics and Bristol-Myers Squibb Announce Clinical Collaboration to Evaluate Combination of Adcetris® (Brentuximab Vedotin) and Opdivo® (Nivolumab) in Hematologic Malignancies
01/12/2015 8:00 AM ET
Seattle Genetics to Present at the J.P. Morgan Healthcare Conference
01/06/2015 9:00 AM ET